Legend Biotech (LEGN) Change in Acquisitions & Divestments (2019 - 2025)

Legend Biotech's Change in Acquisitions & Divestments history runs 7 years deep, the most recent figure standing at $46.7 million for Q4 2025.

• Quarterly Change in Acquisitions & Divestments fell 94.44% year-over-year to $46.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $760.4 million (down 52.41% YoY) and the FY2025 annual result came in at $46.7 million, down 94.44% from the prior year.
• Change in Acquisitions & Divestments was $46.7 million for Q4 2025 at Legend Biotech, up from -$3.6 billion in the prior quarter.
• Across five years, Change in Acquisitions & Divestments topped out at $3.9 billion in Q2 2025 and bottomed at -$3.6 billion in Q3 2025.
• A 5-year average of $297.8 million and a median of $179.4 million in 2021 frame the typical range for Change in Acquisitions & Divestments.
• Annual changes were most pronounced in 2024 — Change in Acquisitions & Divestments jumped 2321.4% — and 2025, when it sank 730.52%.
• Legend Biotech's Change in Acquisitions & Divestments stood at $168.2 million in 2021, then plunged by 67.89% to $54.0 million in 2022, then slumped by 35.75% to $34.7 million in 2023, then soared by 2321.4% to $840.3 million in 2024, then plunged by 94.44% to $46.7 million in 2025.
• Business Quant data shows LEGN's Change in Acquisitions & Divestments at $46.7 million in Q4 2025, -$3.6 billion in Q3 2025, and $3.9 billion in Q2 2025.